SYNAPSE Lab
SYNAPSE Lab
The Sensorimotor Neuroplasticity Âé¶¹APP Lab (SYNAPSE) identifies and validates therapies that promote recovery of movement after spinal cord injury, multiple sclerosis, and stroke.
read more
Âé¶¹APP Spotlight: New Advances in Multiple Sclerosis Rehabilitation
Ongoing Multiple Sclerosis (MS) research at Shirley Ryan Âé¶¹APP aims to help patients improve their long-term outcomes and independence.
read more
Our Projects
Take a look at a few of the projects we work on everyday.
Acute Intermittent Hypoxia-primed myoelectric interface training
PROJECT TYPE:
Gait, Exergaming
Âé¶¹APP Project
Acute Intermittent Hypoxia Initiated Motor Plasticity in MS
PROJECT TYPE:
Gait, Biomedical Engineering
Âé¶¹APP Project
Selected Publications
Towards a Clinically Viable Measurement of Gait Quality: Construction and Validation of a Multiple Sclerosis Gait Deviation Index
This study developed and validated the Multiple Sclerosis¨Cspecific Gait Deviation Index (MS-GDI), a clinically feasible measure of gait quality using low-cost, markerless motion capture with OpenCap. MS-GDI strongly correlated with established clinical measures of mobility and disability, while requiring minimal training and only minutes for analysis, supporting its potential as a scalable tool for routine rehabilitation assessment in persons with Multiple Sclerosis.